| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |